Beta1 integrin blockade overcomes doxorubicin resistance in human T-cell acute lymphoblastic leukemia

Sofiane Berrazouane1, Marc Boisvert1, Suzanne Salti2

  • 1Division of Immune and Infectious Diseases, CHU de Québec-Université Laval Research Center, Quebec city, Canada.

Insights

Beta-1 integrins promote chemoresistance in T-cell acute lymphoblastic leukemia (T-ALL) by enhancing drug efflux. Blocking these integrins sensitizes leukemia cells to doxorubicin, suggesting a new therapeutic target for T-ALL.

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Cell adhesion to the extracellular matrix (ECM) is increasingly recognized for its role in cancer chemoresistance.
  • Beta-1 integrins are expressed by leukemic T cells and mediate interactions with the ECM, but their specific role in T-cell acute lymphoblastic leukemia (T-ALL) chemoresistance is unclear.

Purpose of the Study:

  • To investigate the role of beta-1 integrins in chemoresistance of T-cell acute lymphoblastic leukemia (T-ALL).
  • To explore the underlying mechanisms of beta-1 integrin-mediated chemoresistance and identify potential therapeutic targets.

Main Methods:

  • Utilized human T-ALL cell lines and primary blasts cultured in 3D matrices (Matrigel, collagen type I gel).
  • Employed beta-1 integrin neutralizing antibodies, doxorubicin treatment, and xenograft models in mice.
  • Investigated doxorubicin efflux, ABCC1 drug transporter activation, and the involvement of FAK-related proline-rich tyrosine kinase 2 (PYK2) signaling.

Main Results:

  • Interaction with 3D matrices via beta-1 integrin conferred doxorubicin resistance in T-ALL cells.
  • Blocking beta-1 integrin sensitized T-ALL cells to doxorubicin, reduced leukemic burden, and improved survival in xenograft models.
  • Beta-1 integrin interaction enhanced chemoresistance by promoting doxorubicin efflux via ABCC1 activation and PYK2 signaling.

Conclusions:

  • Beta-1 integrin signaling plays a significant role in mediating chemoresistance in T-cell acute lymphoblastic leukemia.
  • Targeting the beta-1 integrin pathway presents a promising therapeutic strategy to overcome doxorubicin resistance and prevent relapse in T-ALL.

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.3K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
4.9K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.0K
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems01:22

Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems

Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
199
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.4K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
5.7K